If you’re interested in issues involving the disclosure of risks and hazards related to medical care and surgical procedures, you may want to apply to be a member of the Texas Medical Disclosure Panel. The Texas Health and Human Services Commission executive commissioner will appoint a physician and an attorney licensed to practice in Texas to the panel to serve a term expiring Aug. 31, 2028.

Applications are due by 11:59 p.m., May 27.

HHSC will consider applicants' qualifications, background and interest in serving on the panel and will try to choose panel members who represent the diversity of all Texans. For this reason, HHSC considers applicants' ethnicity, gender and geographic location.

• Review the Texas Medical Disclosure Panel Membership application letter to find out who the panel is seeking as representatives and if you qualify.
• After reviewing the application letter and verifying you meet the qualifications for at least one category, click on the application to apply to be on the panel.

A Texas Medical Disclosure Panel member must regularly participate in panel meetings. They may also have to take part in subpanel meetings, projects and presentations. Panel meetings are held about once every three months in Austin or at the call of the presiding officer. To the extent permitted by the current state budget, a panel member may be repaid for their travel expenses to and from meetings if money is available and in accordance with the HHSC Travel Policy.

Federal Register Notice

Requiring Online Submission of Applications for and Renewals of DEA Registration (PDF)

ACTION: Final rule.

SUMMARY: This rulemaking amends the Drug Enforcement Administration's (DEA) regulations to now require all applications for DEA registrations, and renewal of those registrations, to be submitted online.

DATES: This final rule is effective May 11, 2022.

FOR FURTHER INFORMATION CONTACT:
Scott A. Brinks, Regulatory Drafting and Policy Support Section, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 776–2265.

Physicians Call for Better Access to Naloxone, Treatment Programs for Opioids

Read the TMA article 

REPORTING ENTITIES: DATA SUBMISSION IS OPEN!

Program Year 2021 data submission is open now through March 31, 2022. For details about registration, recertification and data submission, visit the Resources for Reporting Entities page.

More information

Take TMB's survey!

TMB is requesting your participation in a very brief customer service survey. Every two years, all state agencies including the Texas Medical Board, are required to conduct a survey about various agency operations. We want to obtain your feedback to help us understand your impression of the TMB’s usage of video conferencing platforms and TMB in general.

The survey consists of 10 multiple choice questions, will take just a few minutes to complete, and is completely anonymous. The survey is available on Survey Monkey via this link: TMB Customer Service Survey.

We respectfully request your participation in the survey by Friday, April 29th, 2022. Your feedback is very important to us and the results of the survey will be published on the agency website as part of the 2022 Strategic Planning process.

FBI Liaison Information Report about Criminals Extorting Medical Professionals by Impersonating Medical Licensing Boards and the FBI. Click link below.

Criminals Extorting Healthcare Professionals

Did you know that TPS has it's very own Career Center?

If you're looking to fill a position, you need to look into this great resource that expands to various medical fields all across the US!

In addition to this resource, we want to help you get the word out. Let us know what positions you're looking for by filling out the form through the link below. 

Open Positions for Members

Below is a recap of the release announced on Forbes. Find the Proposed 2022 CDC Clinical Practice Guideline for Prescribing Opioids here. TPS will submit a formal response on behalf of TPS Members.

Send in your comments directly to TPS

The Centers for Disease Control proposed pulling back some of the strict guidelines for prescribing opioids in a draft of recommendations released Thursday, a move that would loosen some of the restrictions put in place in 2016 to help mitigate the opioid epidemic, in an attempt to allow chronic pain patients to receive more flexible treatment.

KEY FACTS

Be sure to use #TexasPain!

Reminder to Health Care Practitioners About Financial Interest Disclosures

DWC reminds health care practitioners that they must file a financial interest disclosure with DWC when referring an injured employee to another health care practitioner, health care provider, or health care facility that they have a financial interest in.

Do you want to advance your status and exposure? You can with the American Board of Pain Management as a director! You have experiences, opinions, scientific facts that can drive the industry forward. Consider joining by contacting Dr. Finn below. 

HHSC announces new Drug Utilization Review Board appointments

The Texas Health and Human Services Commission established the Drug Utilization Review Board to develop criteria and standards impacting Texas Medicaid, including:

• Developing and submitting recommendations for the Texas Medicaid preferred drug list;
• Suggesting clinical prior authorizations on outpatient prescription drugs;
• Recommending educational interventions for Medicaid providers; and
• Reviewing drug utilization across the Medicaid program.

The following individuals have been selected for Board appointment:

• Dr. Natalie Vanek, physician representative
• Dr. Carlos O. Viesca, physician representative

Please visit the Board webpage for more information on the Board.  Board meeting agendas are posted approximately seven days prior to the meetings on the Events webpage.  Meetings are also webcast and archived on the Meetings webpage for approximately two years from the date of the meeting.